Can some marine-derived fungal metabolites become actual anticancer agents?

Marine Drugs

Volumn 13, Issue 6, 2015, Pages 3950-3991

  Gomes, Nelson G M ^a,b   Lefranc, Florence ^c   Kijjoa, Anake ^a,b   Kiss, Robert ^d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Anticancer; Chemotherapeutic; Cytotoxic; In vivo antitumor; Marine fungi; Multidrug resistance; Natural products; Non apoptotic; Preclinical; Pro apoptotic

Indexed keywords

1403P 3; ALTERPORRIOL K; ANTINEOPLASTIC AGENT; ASPERGIOLIDE A; ASPEROLIDE A; BOSTRYCIN; CISPLATIN; CYTARABINE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; ERIBULIN; FLUOROURACIL; FUMIGACLAVINE C; FUNGAL EXTRACT; GLIOTOXIN; HALIMIDE; HIRSUTANOL A; MITOXANTRONE; NATURAL PRODUCT; OPHIOBOLIN O; PACLITAXEL; PHYSCION; PLINABULIN; SECALONIC ACID D; SZ 685C; TRABECTEDIN; UNCLASSIFIED DRUG; VEDOTIN; WENTILACTONE A;

ACUTE MYELOBLASTIC LEUKEMIA; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BREAST CANCER; BREAST METASTASIS; CANCER EPIDEMIOLOGY; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE ARREST; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LEUKEMIA; LEUKEMIC MENINGITIS; LEWIS CARCINOMA; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOMA; MARINE SPECIES; MAXIMUM TOLERATED DOSE; MULTIDRUG RESISTANCE; NON SMALL CELL LUNG CANCER; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CANCER; REVIEW; SOFT TISSUE SARCOMA; SOLID TUMOR; ANIMAL; AQUATIC SPECIES; DRUG EFFECTS; DRUG RESISTANCE; FUNGUS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; NEOPLASMS; PATHOLOGY; SECONDARY METABOLISM;

FUNGI;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AQUATIC ORGANISMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FUNGI; HUMANS; NEOPLASMS; SECONDARY METABOLISM;

EID: 84936773161     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13063950     Document Type: Review

References (191)

1. Gulland, A. Global cancer prevalence is growing at "alarming pace," says WHO. BMJ 2014, 348, g1338.
2. Torre, L.A.; Bray, F.; Siegel, R.L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015, 65, 87-108.
3. Newman, D.J.; Giddings, L.-A. Natural products as leads to antitumor drugs. Phytochem. Rev. 2014, 13, 123-137.
4. Schiff, P.B.; Horwitz, S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 1980, 77, 1561-1565.
5. Yared, J.A.; Tkaczuk, K.H. Update on taxane development: New analogues and new formulations. Drug Des. Dev. Ther. 2012, 6, 371-384.
6. Duflos, A.; Kruczynski, A.; Barret, J.M. Novel aspects of natural and modified vinca alkaloids. Curr. Med. Chem. Anticancer Agents 2002, 2, 55-70.
7. Mathijseen, R.H.; Loos, W.J.; Verweij, J.; Sparreboom, A. Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan. Curr. Cancer Drug Targets 2002, 2, 103-123.
8. Basili, S.; Moro, S. Novel camptothecin derivatives as topoisomerase I inhibitors. Expert. Opin. Ther. Pat. 2009, 19, 555-574.
9. Gordaliza, M.; Castro, M.A.; del Corral, J.M.; Feliciano, A.S. Antitumor properties of podophyllotoxin and related compounds. Curr. Pharm. Des. 2000, 6, 1811-1839.
10. Lv, M.; Xu, H. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: An update (2008-2010). Mini Rev. Med. Chem. 2011, 11, 901-909.
11. Demain, A.L. Importance of microbial natural products and the need to revitalize their discovery. J. Ind. Microbiol. Biotechnol. 2014, 41, 185-201.
12. Indumathy, S.; Dass, C.R. Finding chemo: The search for marine-based pharmaceutical drugs active against cancer. J. Pharm. Pharmacol. 2013, 65, 1280-1301.
13. Martins, A.; Vieira, H.; Gaspar, H.; Santos, S. Marketed marine natural products in the pharmaceutical and cosmeceutical industries: Tips for success. Mar. Drugs 2014, 12, 1066-1101.
14. Newman, D.J.; Cragg, G.M. Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development. Mar. Drugs 2014, 12, 255-278.
15. Schnekenburger, M.; Dicato, M.; Diederich, M. Epigenetic modulators from "The Big Blue": A treasure to fight against cancer. Cancer Lett. 2014, 351, 182-197.
16. Bergmann, W.; Feeney, R.J. Contributions to the study of marine products. XXXII. The nucleosides of sponges I. J. Org. Chem. 1951, 16, 981-987.
17. Cancer Treatment: Cytarabine. National Cancer Institute. Available online: http://www.cancer.gov/cancertopics/druginfo/cytarabine (accessed on 17 February 2015).
18. Rinehart, K.L.; Holt, T.G.; Fregeau, N.L.; Stroh, J.G.; Keifer, P.A.; Sun, F.; Li, L.H.; Martin, D.G. Ecteinascidins 729, 743, 745, 759A, 759B, and 770: Potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. J. Org. Chem. 1990, 55, 4512-4515.
19. Wright, A.E.; Forleo, D.A.; Gunawardana, G.P.; Gunasekera, S.P.; Koehn, F.E.; McConnell, O.J. Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian Ecteinascidia turbinata. J. Org. Chem. 1990, 55, 4508-4512.
20. European Medicines Agency. Available online: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR---Assessment-Report---Variation/human/000773/WC500059175.pdf (accessed on 17 February 2015).
21. Cuevas, C.; Pérez, M.; Martín, M.J.; Chicharro, J.L.; Fernández-Rivas, C.; Flores, M.; Francesch, A.; Gallego, P.; Zarzuelo, M.; de La Calle, F.; et al. Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B. Org. Lett. 2000, 2, 2545-2548.
22. Hirata, Y.; Uemura, D. Halichondrins - Antitumor polyether macrolides from a marine sponge. Pure Appl. Chem. 1986, 58, 701-710.
23. FDA Approval for Eribulin Mesylate. National Cancer Institute. Available online: http://www.cancer.gov/cancertopics/druginfo/fda-eribulinmesylate (accessed on 17 February 2015).
24. FDA Approval for Brentuximab Vedotin. National Cancer Institute. Available online: http://www.cancer.gov/cancertopics/druginfo/fda-brentuximabvedotin (accessed on 17 February 2015).
25. Pettit, G.R.; Kamano, Y.; Herald, C.L.; Tuinman, A.A.; Boettner, F.E.; Kizu, H.; Schmidt, J.M.; Baczynskyj, L.; Tomer, K.B.; Bontems, R.J. The isolation and structure of a remarkable marine animal antineoplastic constituent: Dolastatin 10. J. Am. Chem. Soc. 1987, 109, 6883-6885.
26. Williamson, R.T.; Chapin, E.L.; Carr, A.W.; Gilbert, J.R.; Graupner, P.R.; Lewer, P.; McKamey, P.; Carney, J.R.; Gerwick, W.H. New diffusion-edited NMR experiments to expedite the dereplication of known compounds from natural product mixtures. Org. Lett. 2000, 2, 289-292.
27. Luesch, H.; Moore, R.E.; Paul, V.J.; Mooberry, S.L.; Corbett, T.H. Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1. J. Nat. Prod. 2001, 64, 907-910.
28. Petit, K.; Biard, J.-F. Marine natural products and related compounds as anticancer agents: An overview of their clinical status. Anticancer Agents Med. Chem. 2013, 13, 603-631.
29. Aly, A.H.; Debbab, A.; Proksch, P. Fifty years of drug discovery from fungi. Fungal Divers. 2011, 50, 3-19.
30. Kück, U.; Bloemendal, S.; Teichert, I. Putting fungi to work: Harvesting a cornucopia of drugs, toxins, and antibiotics. PLoS Pathog. 2014, 10, e1003950.
31. Rateb, M.E.; Ebel, R. Secondary metabolites of fungi from marine habitats. Nat. Prod. Rep. 2011, 28, 290-344.
32. Bugni, T.S.; Ireland, C.M. Marine-derived fungi: A chemically and biologically diverse group of microorganisms. Nat. Prod. Rep. 2004, 21, 143-163.
33. Saleem, M.; Shaiq Ali, M.; Hussain, S.; Jabbar, A.; Ashraf, M.; Lee, Y.S. Marine natural products of fungal origin. Nat. Prod. Rep. 2007, 24, 1142-1152.
34. Abraham, E.P. A glimpse of the early history of the cephalosporins. Rev. Infect. Dis. 1979, 1, 99-105.
35. Evidente, A.; Kornienko, A.; Cimmino, A.; Andolfi, A.; Lefranc, F.; Mathieu, V.; Kiss, R. Fungal metabolites with anticancer activity. Nat. Prod. Rev. 2014, 31, 617-627.
36. Cotter, T.G. Apoptosis and cancer: The genesis of a research field. Nat. Rev. Cancer 2009, 9, 501-507.
37. Giansanti, V.; Tillhon, M.; Mazzini, G.; Prosperi, E.; Lombardi, P. Scovassi, A.I. Killing of tumor cells: A drama in two acts. Biochem. Pharmacol. 2011, 82, 1304-1310.
38. Indran, I.R.; Tufo, G.; Pervaiz, S.; Brenner, C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim. Biophys. Acta 2011, 1807, 735-745.
39. Nagaprashantha, L.; Vartak, N.; Awasthi, S.; Awasthi, S.; Singhal, S.S. Novel anti-cancer compounds for developing combinatorial therapies to target anoikis-resistant tumors. Pharm. Res. 2012, 29, 621-636.
40. Taddei M.L.; Giannoni, E.; Fiaschi, T.; Chiarugi, P. Anoikis: An emerging hallmark in health and diseases. J. Pathol. 2012, 226, 380-393.
41. Galluzzi, L.; Vitale, I.; Abrams, J.M.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; Dawson, T.M.; Dawson, V.L.; El-Deiry, W.S.; Fulda, S.; et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Diff. 2012, 19, 107-120.
42. Kornienko, A.; Mathieu, V.; Rastogi, S.K.; Lefranc, F.; Kiss, R. Therapeutic agents triggering nonapoptotic cancer cell death. J. Med. Chem. 2013, 56, 4823-4839.
43. Takahashi, C.; Numata, A.; Ito, Y.; Matsumura, E.; Araki, H.; Iwaki, H.; Kushida, K. Leptosins, antitumour metabolites of a fungus isolated from a marine alga. J. Chem. Soc. Perkin Trans. 1994, 1, 1859-1864.
44. Takahashi, C.; Numata, A.; Matsumura, E.; Minoura, K.; Eto, H.; Shingu, T.; Ito, T.; Hasegawa, T. Leptosins I and J, cytotoxic substances produced by a Leptosphaeria sp. Physico-chemical properties and structures. J. Antibiot. (Tokyo) 1994, 47, 1242-1249.
45. Takahashi, C.; Takai, Y.; Kimura, Y.; Numata, A.; Shigematsu, N.; Tanaka, H. Cytotoxic metabolites from a fungal adherent of a marine alga. Phytochemistry 1995, 38, 155-158.
46. Takahashi, C.; Minoura, K.; Yamada, T.; Numata, A.; Kushida, K.; Shingu, T.; Hagishita, S.; Nakai, H.; Sato, T.; Harada, H. Potent cytotoxic metabolites from a Leptosphaeria species. Structure determination and conformational analysis. Tetrahedron 1995, 51, 3483-3498.
47. Yamada, T.; Iwamoto, C.; Yamagaki, N.; Yamanouchi, T.; Minoura, K.; Yamori, T.; Uehara, Y.; Andoh, T.; Umemura, K.; Numata, A. Leptosins M-N1, cytotoxic metabolites from a Leptosphaeria species separated from a marine alga. Structure determination and biological activities. Tetrahedron 2002, 58, 479-487.
48. Yamada, T.; Iwamoto, C.; Yamagaki, N.; Yamanouchi, T.; Minoura, K.; Hagishita, S.; Numata, A. Leptosins O-S, cytotoxic metabolites from a strain of Leptosphaeria sp. isolated from a marine alga. Heterocycles 2004, 63, 641-653.
49. Yanagihara, M.; Sasaki-Takahashi, N.; Sugahara, T.; Yamamoto, S.; Shinomi, M.; Yamashita, I.; Hayashida, M.; Yamanoha, B.; Numata, A.; Yamori, T.; et al. Leptosins isolated from marine fungus Leptoshaeria species inhibit DNA topoisomerases I and/or II and induce apoptosis by inactivation of Akt/protein kinase B. Cancer Sci. 2005, 96, 816-824.
50. Kalimuthu, S.; Se-Kwon, K. Cell survival and apoptosis signaling as therapeutic target for cancer: Marine bioactive compounds. Int. J. Mol. Sci. 2013, 14, 2334-2354.
51. Choi, E.J.; Park, S.J.; Kim, Y.J.; Jung, J.H.; Lee, J.K.; Kwon, H.C.; Yang, H.O. Apoptosis-inducing effect of diketopiperazine disulfides produced by Aspergillus sp. KMD901 isolated from marine sediment on HCT116 colon cancer cell lines. J. Appl. Microbiol. 2011, 110, 304-313.
52. Li, X.; Kim, S.K.; Nam, K.W.; Kang, J.S.; Choi, H.D.; Son, B.W. A new bacterial dioxopiperazine alkaloid related to gliotoxin from a marine isolate of the fungus Pseudallescheria. J. Antibiot. 2006, 59, 248-250.
53. Sun, Y.; Takada, K.; Takemoto, Y.; Yoshida, M.; Nogi, Y.; Okada, S.; Matsunaga, S. Gliotoxin analogues from a marine-derived fungus, Penicillium sp., and their cytotoxic and histone methyltransferase inhibitory activities. J. Nat. Prod. 2012, 75, 111-114.
54. Liang, W.L.; le, X.; Li, H.J.; Yang, X.L.; Chen, J.X.; Xu, J.; Liu, H.L.; Wang, L.Y.; Wang, K.T.; Hu, K.C.; et al. Exploring the chemodiversity and biological activities of the secondary metabolites from the marine fungus Neosartorya pseudofischeri. Mar. Drugs 2014, 12, 5657-5676.
55. Nguyen, V.T.; Lee, J.S.; Qian, Z.J.; Li, Y.X.; Kim, K.N.; Heo, S.J.; Jeon, Y.J.; Park, W.S.; Choi, I.W.; Je, J.Y.; et al. Gliotoxin isolated from marine fungus Aspergillus sp. induces apoptosis of human cervical cancer and chondrosarcoma cells. Mar. Drugs 2014, 12, 69-87.
56. Zhang, F.L.; Casey, P.J. Protein prenylation: Molecular mechanisms and functional consequences. Annu. Rev. Biochem. 1996, 65, 241-269.
57. Vigushin, D.M.; Mirsaidi, N.; Brooke, G.; Sun, C.; Pace, P.; Inman, L.; Moody, C.J.; Coombes, R.C. Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo. Med. Oncol. 2004, 21, 21-30.
58. Albert, M.; Helin, K. Histone methyltransferases in cancer. Semin. Cell. Dev. Biol. 2010, 21, 209-220.
59. Xu, M.; Gessner, G.; Groth, I.; Lange, C.; Christner, A.; Bruhn, T.; Deng, Z.; Li, X.; Heinemann, S.H.; Grabley, S.; et al. Shearinines D-K, new indole triterpenoids from an endophytic Penicillium sp. (strain HKI0459) with blocking activity on large-conductance calcium-activated potassium channels. Tetrahedron 2007, 63, 435-444.
60. Smetanina, O.F.; Kalinovsky, A.I.; Khudyakova, Y.V.; Pivkin, M.V.; Dmitrenok, P.S.; Fedorov, S.N.; Ji, H.; Kwak, J.-Y.; Kuznetsova, T.A. Indole alkaloids produced by a marine fungus isolate of Penicillium janthinellum Biourge. J. Nat. Prod. 2007, 70, 906-909.
61. Smetanina, O.F.; Kalinovsky, A.I.; Khudyakova, Y.V.; Pivkin, M.V.; Dmitrenok, P.S.; Fedorov, S.N.; Ji, H.; Kwak, J.-Y.; Kuznetsova, T.A. Erratum [Indole alkaloids produced by a marine fungus isolate of Penicillium janthinellum Biourge.]. J. Nat. Prod. 2007, 70, 2054.
62. Du, L.; Feng, T.; Zhao, B.; Li, D.; Cai, S.; Zhu, T.; Wang, F.; Xiao, X.; Gu, Q. Alkaloids from a deep ocean sediment-derived fungus Penicillium sp. and their antitumor activities. J. Antibiot. 2010, 63, 165-170.
63. Du, L.; Li, D.; Zhu, T.; Cai, S.; Wang, F.; Xiao, X.; Gu, Q. New alkaloids and diterpenes from a deep ocean sediment derived fungus Penicillium sp. Tetrahedron 2009, 65, 1033-1039.
64. Shang, Z.; Li, X.; Meng, L.; Li, C.; Gao, S.; Huang, C.; Wang, B. Chemical profile of the secondary metabolites produced by a deep-sea sediment-derived fungus Penicillium commune SD-118. Chin. J. Oceanol. Limnol. 2012, 30, 305-314.
65. Zheng, C.J.; Sohn, M.-J.; Lee, S.; Kim, W.-G. Meleagrin, a new FabI inhibitor from Penicillium chryosogenum with at least one additional mode of action. PLoS ONE 2013, 8, e78922.
66. Li, D.L.; Li, X.M.; Li, T.G.; Dang, H.Y.; Wang, B.G. Dioxopiperazine alkaloids produced by the marine mangrove derived endophytic fungus Eurotium rubrum. Helv. Chim. Acta 2008, 91, 1888-1893.
67. Gomes, N.M.; Dethoup, T.; Singburaudom, N.; Gales, L.; Silva, A.M.S.; Kijjoa, A. Eurocristatine, a new diketopiperazine dimer from the marine sponge-associated fungus Eurotium cristatum. Phytochem. Lett. 2012, 5, 717-720.
68. Kim, K.S.; Cui, X.; Lee, D.S.; Sohn, J.H.; Yim, J.H.; Kim, Y.C.; Oh, H. Anti-inflammatory effect of neoechinulin A from the marine fungus Eurotium sp. SF-5989 through the suppression of NF-κB and p38 MAPK pathways in lipopolysaccharide-stimulated RAW264.7 macrophages. Molecules, 2013, 18, 13245-13259.
69. Wijesekara, I.; Li, X.Y.; Uo, T.S.; van Ta, Q.; Ngo, D.H.; Kim, S.K. Induction of apoptosis in human cervical carcinoma HeLa cells by neoechinulin A from marine-derived fungus Microsporum sp. Process Biochem. 2013, 48, 68-72.
70. Li, Y.X.; Himaya, S.W.A.; Dewapriya, P.; Zhang, C.; Kim, S.K. Fumigaclavine C from a marine-derived fungus Aspergillus fumigatus induces apoptosis in MCF-7 breast cancer cells. Mar. Drugs 2013, 11, 5063-5086.
71. Jiang, G.C.; Lin, Y.C.; Zhou, S.N.; Vrumoed, L.L.P.; Jones, E.B.G. Studies of the secondary metabolites of mangrove fungus No. 1403 from the South China Sea. Acta Sci. Nat. Univ. Sunyatseni 2000, 39, 68-72.
72. Xu, J.; Nakazawa, T.; Ukai, K.; Kobayashi, H.; Mangindaan, R.E.P.; Wewengkang, D.S.; Rotinsulu, H.; Namikoshi, M. Tetrahydrobostrycin and 1-deoxytetrahydrobostrycin, two new hexahydroanthrone derivatives, from a marine-derived fungus Aspergillus sp. J. Antibiot. 2008, 61, 415-419.
73. Trisuwan, K.; Khamthong, N.; Rukachaisirikul, V.; Phongpaichit, S.; Preedanon, S.; Sakayroj, J. Anthraquinone, cyclopentanone, and naphthoquinone derivatives from the sea fan-derived fungi Fusarium spp. PSU-F14 and PSU-F135. J. Nat. Prod. 2010, 73, 1507-1511.
74. Huang, X.; Sun, X.; Lin, S.; Xiao, Z.; Li, H.; Bo, D.; She, Z. Xylanthraquinone, a new anthraquinone from the fungus Xylaria sp. 2508 from the South China Sea. Nat. Prod. Res. 2014, 28, 111-114.
75. Chen, W.S.; Hou, J.N.; Guo, Y.B.; Yang, H.L.; Xie, C.M.; Lin, Y.C.; She, Z.G. Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway. J. Exp. Clin. Cancer Res. 2011, 30, 17.
76. Xu, C.; Wang, J.; Gao, Y.; Lin, H.; Du, L.; Yang, S.; Long, S.; She, Z.; Cai, X.; Zhou, S.; et al. The anthracenedione compound bostrycin induces mitochondria-mediated apoptosis in the yeast Saccharomyces cerevisiae. FEMS Yeast Res. 2010, 10, 297-308.
77. Chen, H.; Zhong, L.; Long, Y.; Li, J.; Wu, J.; Liu, L.; Chen, S.; Lin, Y.; Li, M.; Zhu, X.; et al. Studies on the synthesis of derivatives of marine-derived bostrycin and their structure-activityrelationship against tumor cells. Mar. Drugs 2012, 10, 932-952.
78. Xie, G.; Zhu, X.; Li, Q.; Gu, M.; He, Z.; Wu, J.; Li, J.; Lin, Y.; Li, M.; She, Z.; et al. SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway. Br. J. Pharmacol. 2010, 159, 689-697.
79. Wang, D.; Wang, S.; Liu, Q.; Wang, M.; Wang, C.; Yang, H. SZ-685C exhibits potent anticancer activity in both radiosensitive and radioresistant NPC cells through the miR-205-PTEN-Akt pathway. Oncol. Rep. 2013, 29, 2341-2347.
80. Zhu, X.; He, Z.; Wu, J.; Yuan, J.; Wen, W.; Hu, Y.; Jiang, Y.; Lin, C.; Zhang, Q.; Lin, M.; et al. A marine anthraquinone SZ-685C overrides adriamycin-resistance in breast cancer cells through suppressing Akt signaling. Mar. Drugs 2012, 10, 694-711.
81. Yuan, J.; He, Z.; Wu, J.; Lin, Y.; Zhu, X. A novel adriamycin analogue derived from marine microbes induces apoptosis by blocking Akt activation in human breast cancer cells. Mol. Med. Rep. 2011, 4, 261-265.
82. Zhang, J.Y.; Wu, H.Y.; Xia, X.K.; Liang, Y.J.; Yan, Y.Y.; She, Z.G.; Lin Y.C.; Fu, L.W. Anthracenedione derivative 1403P-3 induces apoptosis in KB and KBv200 cells via reactive oxygen species-independent mitochondrial pathway and death receptor pathway. Cancer Biol. Ther. 2007, 6, 1409-1417.
83. Huang, C.-H.; Pan, J.-H.; Chen, B.; Yu, M.; Huang, H.-B.; Zhu, X.; Lu, Y.-J.; She, Z.-G.; Lin, Y.-C. Three bianthraquinone derivatives from the mangrove endophytic fungus Alternaria sp. ZJ9-6B from the South China Sea. Mar. Drugs 2011, 9, 832-843.
84. Huang, C.; Jin, H.; Song, B.; Zhu, X.; Zhao, H.; Cai, J.; Lu, Y.; Chen, B.; Lin, Y. The cytotoxicity and anticancer mechanisms of alterporriol L, a marine bianthraquinone, against MCF-7 human breast cancer cells. Appl. Microbiol. Biotechnol. 2012, 93, 777-785.
85. Du, L.; Zhu, T.; Fang, Y.; Liu, H.; Gu, Q.; Zhu, W. Aspergiolide A, a novel anthraquinones derivative with naphtho[1,2,3-de]chromene-2,7-dione skeleton isolated from a marine-derived fungus Aspergillus glaucus. Tetrahedron 2007, 63, 1085-1088.
86. Du, L.; Zhu, T.; Fang, Y.; Liu, H.; Gu, Q.; Zhu, W. Corrigendum to "Aspergiolide A, a novel anthraquinones derivative with naphtho[1,2,3-de]chromene-2,7-dione skeleton isolated from a marine-derived fungus Aspergillus glaucus" [Tetrahedron 63 (2007) 1085]. Tetrahedron 2008, 64, 4657.
87. Du, L.; Zhu, T.; Liu, H.; Fang, Y.; Zhu, W.; Gu, Q. Cytotoxic polyketides from a marine-derived fungus Aspergillus glaucus. J. Nat. Prod. 2008, 71, 1837-1842.
88. Du, D.; Du, L.; Ai, J.; Li, D.; Zhu, T.; Wang, Y.; Knauer, M.; Bruhn, T.; Liu, H.; Geng, M.; et al. Aspergiolides C and D: Spirocyclic aromatic polyketides with potent protein kinase c-Met inhibitory effects. Chem. Eur. J. 2011, 17, 1319-1326.
89. Wang, Y.; Qi, X.; Li, D.; Zhu, T.; Mo, X.; Li, J. Anticancer efficacy and absorption, distribution, metabolism and toxicity studies of Aspergiolide A in early drug development. Drug Design Dev. Ther. 2014, 8, 1965-1977.
90. Wijesekara, I.; Zhang, C.; Ta, Q.V.; Vo, T.S.; Li, Y.X.; Kim, S.K. Physcion from marine-derived fungus Microsporum sp. induces apoptosis in human cervical carcinoma HeLa cells. Microbiol. Res. 2014, 169, 255-261.
91. Du, L.; Li, D.; Zhang, G.; Zhu, T.; Ai, J.; Gu, Q. Novel carbon-bridged citrinin dimers from a volcano-ash derived fungus Penicillium citrinum and their cytotoxic and cell cycle arrest activities. Tetrahedron 2010, 66, 9286-9290.
92. Chen, L.; Gong, M.W.; Peng, Z.F.; Zhou, T.; Ying, M.G.; Zheng, Q.H.; Liu, Q.Y.; Zhang, Q.Q. The marine fungal metabolite, dicitrinone B, induces A375 cell apoptosis through the ROS-related caspase pathway. Mar. Drugs 2014, 12, 1939-1958.
93. Zhao, W.Y.; Zhu, Q.; Gu, Q. Studies on chemical constituents of secondary metabolites of marine-derived Aspergillus fumigatus. J. Qingdao Univ. Sci. Technol. (Nat. Sci. Ed.) 2007, 3, 199-201.
94. Klaiklay, S.; Rukachaisirikul, V.; Sukpondma, Y.; Phongpaichit, S.; Buatong, J.; Bussaban, B. Metabolites from the mangrove-derived fungus Xylaria cubensis PSU-MA34. Arch. Pharm. Res. 2012, 35, 1127-1131.
95. Tian, Y.Q.; Lin, X.P.; Liu, J.; Kaliyaperumal, K.; Ai, W.; Ju, Z.R.; Yang, B.; Wang, J.; Yang, X.W.; Liu, Y. Ascomycotin A, a new citromycetin analogue produced by Ascomycota sp. Ind19F07 isolated from deep sea sediment. Nat. Prod. Res. 2015, 29, 820-826.
96. Li, Y.X.; Himaya, S.W.A.; Dewapriya, P.; Kim, H.J.; Kim, S.K. Anti-proliferative effects of isosclerone isolated from marine fungus Aspergillus fumigatus in MCF-7 human breast cancer cells. Process Biochem. 2014, 49, 2292-2298.
97. Li, Y.X.; Kang, K.H.; Kim, H.J.; Kim, S.K. In vitro induction of apoptosis by isosclerone from marine-derived fungus Aspergillus fumigatus. Bioorg. Med. Chem. Lett. 2014, 24, 3923-3927.
98. Oh, H.; Jensen, P.R.; Murphy, B.T.; Fiorilla, C.; Sullivan, J.F.; Ramsey, T.; Fenical, W. Cryptosphaerolide: A Cytotoxic Mcl-1 Inhibitor from a Marine-Derived Ascomycete Related to the Genus Cryptosphaeria. J. Nat. Prod. 2010, 73, 998-1001.
99. Belmar, J.; Fesik, S.W. Small molecule Mcl-1 inhibitors for the treatment of cancer. Pharmacol. Ther. 2015, 145C, 76-84.
100. Li, Y.; Li, X.F.; Kim, D.S.; Choi, H.D.; Son, B.W. Indolyl alkaloid derivatives, Nb-acetyltryptamine and oxaline from a marine-derived fungus. Arch. Pharm. Res. 2003, 26, 21-23.
101. Jadulco, R.; Edrada, R.A.; Ebel, R.; Berg, A.; Schaumann, K.; Wray, V.; Steube, K.; Proksch, P. New communesin derivatives from the fungus Penicillium sp. derived from the Mediterranean sponge Axinella verrucosa. J. Nat. Prod. 2004, 67, 78-81.
102. Koizumi, Y.; Arai, M.; Tomoda, H.; Omura, S. Oxaline, a fungal alkaloid, arrests the cell cycle in M phase by inhibition of tubulin polymerization. Biochim. Biophys. Acta 2004, 1693, 47-55.
103. Lee, S.U.; Asami, Y.; Lee, D.; Jang, J.H.; Ahn, J.S.; Oh, H. Protuboxepins A and B and protubonines A and B from the marine-derived fungus Aspergillus sp. SF-5044. J. Nat. Prod. 2011, 74, 1284-1287.
104. Ebada, S.S.; Fischer, T.; Hamacher, A.; Du, F.Y.; Roth, Y.O.; Kassack, M.U., Wang, B.G.; Roth, E.H. Psychrophilin E, a new cyclotripeptide, from co-fermentation of two marine alga-derived fungi of the genus Aspergillus. Nat. Prod. Res. 2014, 28, 776-781.
105. Asami, Y.; Jang, J.-H.; Soung, N.-K.; He, L.; Moon, D.O.; Kim, J.W.; Oh, H.; Muroi, M.; Osada, H.; Kim, B.Y.; et al. Protuboxepin A, a marine fungal metabolite, inducing metaphase arrest and chromosomal misalignment in tumor cells. Bioorg. Med. Chem. 2012, 20, 3799-3806.
106. Mohamed, I.E.; Gross, H.; Pontius, A.; Kehraus, S.; Krick, A.; Kelter, G.; Maier, A.; Fiebig, H.H.; König, G.M. Epoxyphomalin A and B, prenylated polyketides with potent cytotoxicity from the marine-derived fungus Phoma sp. Org. Lett. 2009, 11, 5014-5017.
107. Mohamed, I.E.; Kehraus, S.; Krick, A.; König, G.M.; Kelter, G.; Maier, A.; Fiebig, H.-H.; Kalesse, M.; Malek, N.P.; Gross, H. Mode of action of epoxyphomalins a and b and characterization of related metabolites from the marine-derived fungus Paraconiothyrium sp. J. Nat. Prod. 2010, 73, 2053-2056.
108. Namikoshi, M.; Kobayashi, H.; Yoshimoto, T.; Hosoya, T. Phomopsidin, a new inhibitor of microtubule assembly produced by Phomopsis sp. isolated from coral reef in Pohnpei. J. Antibiot. (Tokyo) 1997, 50, 890-892.
109. Namikoshi, M.; Kobayashi, H.; Yoshimoto, T.; Meguro, S.; Akano, K. Isolation and characterization of bioactive metabolites from marine-derived filamentous fungi collected from tropical and sub-tropical coral reefs. Chem. Pharm. Bull. 2000, 48, 1452-1457.
110. Kobayashi, H.; Sunaga, R.; Furihata, K.; Morisaki, N.; Iwasaki, S. Isolation and structures of an antifungal antibiotic, fusarielin A, and related compounds produced by a Fusarium sp. J. Antibiot. (Tokyo) 1995, 48, 42-52.
111. Kobayashi, H.; Meguro, S.; Yoshimoto, T.; Namikoshi, M. Absolute structure, biosynthesis, and anti-microtubule activity of phomopsidin, isolated from a marine-derived Phomopsis sp. Tetrahedron 2003, 59, 455-459.
112. Kobayashi, H.; Meguro, S.; Yoshimoto, T.; Namikoshi, M. Corrigendum to "Absolute structure, biosynthesis, and anti-microtubule activity of phomopsidin, isolated from a marine-derived Phomopsis sp." [Tetrahedron 59 (2003) 455-459] Tetrahedron 2004, 60, 1255.
113. Osterhage, C.; Kaminsky, R.; König, G.M.; Wright, A.D. Ascosalipyrrolidinone A, an antimicrobial alkaloid, from the obligate marine fungus Ascochyta salicorniae. J. Org. Chem. 2000, 65, 6412-6417.
114. Myobatake, Y.; Takeuchi, T.; Kuramochi, K.; Kuriyama, I.; Ishido, T.; Hirano, K.; Sugawara, F.; Yoshida, H.; Mizushina, Y. Pinophilins A and B, inhibitors of mammalian A-, B-, and Y-family DNA polymerases and human cancer cell proliferation. J. Nat. Prod. 2012, 75, 135-141.
115. Abdel-Lateff, A.; Klemke, C.; König, G.M.; Wright, A.D. Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus. J. Nat. Prod. 2003, 66, 706-708.
116. Ebada, S.S.; Schulz, B.; Wray, V.; Totzke, F.; Kubbutat, M.H.G.; Muller, W.E.G.; Hamacher, A.; Kassack, M.U.; Lin, W.; Proksch, P. Arthrinins A-D: Novel diterpenoids and further constituents from the sponge derived fungus Arthrinium sp. Bioorg. Med. Chem. 2011, 19, 4644-4651.
117. Abdel-Lateff, A. Chaetominedione, a new tyrosine kinase inhibitor isolated from the algicolous marine fungus Chaetomium sp. Tetrahedron Lett. 2008, 49, 6398-6400.
118. Szigligeti, P.; Neumeier, L.; Duke, E.; Chougnet, C.; Takimoto, K.; Lee, S.M.; Filipovich, A.H.; Conforti, L. Signalling during hypoxia in human T lymphocytes - Critical role of the Src protein tyrosine kinase p56Lck in the O2 sensitivity of Kv1.3 channels. J. Physiol. 2006, 573, 357-370.
119. Alvi, K.A.; Casey, A.; Nair, B.G. Pulchellalactam: A CD45 protein tyrosine phosphatase inhibitor from the marine fungus Corollospora pulchella. J. Antibiot. (Tokyo) 1998, 51, 515-517.
120. Gu, W.; Cueto, M.; Jensen, P.R.; Fenical, W.; Silverman, R.B. Microsporins A and B: New histone deacetylase inhibitors from the marine-derived fungus Microsporum cf. gypseum and the solid-phase synthesis of microsporin A. Tetrahedron 2007, 63, 6535-6541.
121. Hayakawa, Y.; Hattori, Y.; Kawasaki, T.; Kanoh, K.; Adachi, K.; Shizuri, Y.; Shin-Ya, K. Efrapeptin J, a new down-regulator of the molecular chaperone GRP78 from a marine Tolypocladium sp. J. Antibiot. 2008, 61, 365-371.
122. Roller, C.; Maddalo, D. The molecular chaperone GRP78/BiP in the development of chemoresistance: Mechanism and possible treatment. Front. Pharmacol. 2013, 4, 10.
123. Shenolikar, S. Dangerous liaisons: Flirtations between oncogenic BRAF and GRP78 in drug-resistant melanomas. J. Clin. Invest. 2014, 124, 973-976.
124. Numata, A.; Iritani, M.; Yamada, T.; Minoura, K.; Matsumura, E.; Yamori, T.; Tsuruo, T. Novel antitumor metabolites produced by a fungal strain from a sea hare. Tetrahedron Lett. 1997, 38, 8215-8218.
125. Yamada, T.; Iritani, M.; Ohishi, H.; Tanaka, K.; Minoura, K.; Doi, M.; Numata, A. Pericosines, antitumour metabolites from the sea hare-derived fungus Periconia byssoides. Structures and biological activities. Org. Biomol. Chem. 2007, 5, 3979-3986.
126. Usami, Y.; Hatsuno, C.; Yamamoto, H.; Tanabe, M.; Numata, A. Synthesis of the epimer of pericosine B from (-)-quinic acid. Chem. Pharm. Bull. 2004, 52, 1130-1133.
127. Darro, F.; Decaestecker, C.; Gaussin, J.F.; Mortier, S.; van Ginckel, R.; Kiss, R. Are syngeneoic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? Int. J. Oncol. 2005, 27, 607-616.
128. McDonald, L.A.; Abbanat, D.R.; Barbieri, L.R.; Beruan, V.S.; Discafani, C.M.; Greenstein, M.; Janota, K.; Korshalla, J.D.; Lassota, P.; Tischler M.; et al. Spiroxins, DNA cleaving antitumor antibiotics from a marine-derived fungus. Tetrahedron Lett. 1999, 40, 2489-2492.
129. Westin, S.N.; Herzog, T.J.; Coleman, R.L. Investigational agents in development for the treatment of ovarian cancer. Invest. New Drugs 2013, 31, 213-229.
130. Lao, J.; Madani, J.; Puértolas, T.; Alvarez, M.; Hernández, A.; Pazo-Cid, R.; Artal, A.; Antón Torres, A. Liposomal Doxorubicin in the treatment of breast cancer patients: A review. J. Drug Deliv. 2013, 456409.
131. DeSantis, C.; Ma, J.; Bryan, L.; Jemal, A. Breast cancer statistics, 2013. CA Cancer J. Clin. 2014, 64, 52-62.
132. Tryfonidis, K.; Senkus, E.; Cardoso, M.J.; Cardoso, F. Management of locally advanced breast cancer-perspectives and future directions. Nat. Rev. Clin. Oncol. 2015, in press.
133. Knuefermann, C.; Lu, Y.; Liu, B.; Jin, W.; Liang, K.; Wu, L.; Schmidt, M.; Mills, G.B.; Mendelsohn, J.; Fan, Z. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 2003, 22, 3205-3212.
134. Yang, T.; Lu, Z.; Meng, L.; Wei, S.; Hong, K.; Zhu, W.; Huang, C. The novel agent ophiobolin O induces apoptosis and cell cycle arrest of MCF-7 cells through activation of MAPK signaling pathways. Bioorg. Med. Chem. Lett. 2012, 22, 579-585.
135. Lv, C.; Qin, W.; Zhu, T.; Wei, S.; Hong, K.; Zhu, W.; Chen, R.; Huang, C. Ophiobolin O isolated from Aspergillus ustus induces G1 arrest of MCF-7 cells through interaction with AKT/GSK3beta/cyclin D1 signaling. Mar. Drugs 2015, 13, 431-443.
136. Sun, W.; Lu, C.; Zhu, T.; Yang, X.; Wei, S.; Sun, J.; Hong, K.; Zhu, W.; Huang, C. Ophiobolin-O reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human breast carcinoma (MCF-7/ADR) cells. Mar. Drugs 2013, 11, 4570-4584.
137. Ren, H.; Tian, L.; Gu, Q.; Zhu, W. Secalonic acid D; a cytotoxic constituent from marine lichen-derived fungus Gliocladium sp. T31. Arch. Pharm. Res. 2006, 29, 59-63.
138. Zhang, J.Y.; Tao, L.Y.; Liang, Y.J.; Yan, Y.Y.; Dai, C.L.; Xia, X.K.; She, Z.G.; Lin, Y.C.; Fu, L.W. Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G1 with involvement of GSK-3β/β-catenin/c-Myc pathway. Cell Cycle 2009, 8, 2444-2450.
139. Antia, B.S.; Aree, T.; Kasettrathat, C.; Wiyakrutta, S.; Ekpa, O.D.; Ekpe, U.J.; Mahidol, C.; Ruchirawat, S.; KIttakoop, P. Itanoic acid derivatives and diketopiperazine from the marine-derived fungus Aspergillus aculeatus CRI322-03. Phytochemistry 2011, 72, 816-820.
140. Bao, J.; Sun, Y.L.; Zhang, X.Y.; Han, Z.; Gao, H.C.; He, F.; Qian, P.Y.; Qi, S.H. Antifouling and antibacterial polyketides from marine gorgonian coral-associated fungus Penicillium sp. SCSGAF 0023. J. Antibiot. 2013, 66, 219-223.
141. Chen, G.; Jiang, Z.; Bai, J.; Wang, H.; Zhang, S.; Pei, Y. Isolation, structure determination, in vivo/vitro assay and docking study of a xanthone with antitumor activity from fungus Penicillium oxalicum. Rec. Nat. Prod. 2015, 9, 184-189.
142. Kurobane, I.; Iwahashi, S.; Fukuda, A. Cytostatic activity of naturally isolated isomers of secalonic acids and their chemically rearranged dimers. Drugs Exp. Clin. Res. 1987, 13, 339-344.
143. Hu, Y.P.; Tao, L.Y.; Wang, F.; Zhang, J.Y.; Liang, Y.J.; Fu, L.W. Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABCG2. Biochem. Pharmacol. 2013, 85, 1619-1625.
144. Volk, E.I.; Farley, K.M.; Wu, Y.; Li, F.; Robey, R.W.; Schneider, E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res. 2002, 62, 5035-5040.
145. Hong, R. Secalonic acid D as a novel DNA topoisomerase I inhibitor from marine lichen-derived fungus Gliocladium sp. T31. Pharm. Biol. 2011, 49, 796-799.
146. Shimizu, M.; Nakamura, M.; Kataoka, T.; Iwaguchi, T. Mechanism of the antitumor activity of 5,5′-bis(2′-tetrahydropyranil) secalonic acid D against Meth-A. Cancer Chemother. Pharmacol. 1983, 11, 144-146.
147. Sun, H.F.; Li, X.M.; Meng, L.; Cui, C.M.; Gao, S.S.; Li, C.S.; Huang, C.G.; Wang, B.G. Asperolides A-C, tetranorlabdane diterpenoids from the marine alga-derived endophytic fungus Aspergillus wentii EN-48. J. Nat. Prod. 2012, 75, 148-152.
148. Lv, C.; Sun, W.; Sun, H.; Wei, S.; Chen, R.; Wang, B.; Huang, C. Asperolide A, a marine-derived tetranorditerpenoid, induces G2/M arrest in human NCI-H460 lung carcinoma cells, is mediated by p53-p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway. Mar. Drugs 2013, 11, 316-331.
149. Lv, C.; Hong, Y.; Miao, L.; Li, C.; Xu, G.; Wei, S.; Wang, B.; Huang, C.; Jiao, B. Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway. Cell Death Dis. 2013, 4, e952.
150. Zhang, Z.; Miao, L.; Lv, C.; Sun, H.; Wei, S.; Wang, B.; Huang, C.; Jiao, B. Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells. Cell Death Dis. 2013, 4, e657.
151. Zhang, Z.; Miao, L.; Sun, W.; Jiao, B.; Wang, B.; Yao, L.; Huang, C. Wentilactone B from Aspergillus wentii induces apoptosis and inhibits proliferation and migration of human hepatoma SMMC-7721 cells. Biol. Pharm. Bull. 2012, 35, 1964-1971.
152. Wang, G.Y.S.; Abrell, L.M.; Avelar, A.; Borgeson, B.M.; Crews, P. New hirsutane based sesquiterpenes from salt water cultures of a marine sponge-derived fungus and the terrestrial fungus Coriolus consors. Tetrahedron 1998, 54, 7335-7342.
153. Li, H.J.; Lan, W.J.; Lam, C.K.; Yang, F.; Zhu, X.F. Hirsutane sesquiterpenoids from the marine-derived fungus Chondrostereum sp. Chem. Biodivers. 2011, 8, 317-324.
154. Li, H.J.; Xie, Y.L.; Xie, Z.L.; Chen, Y.; Lam, C.K.; Lan, W.J. Chondrosterins A-E, triquinane-type sesquiterpenoids from soft coral-associated fungus Chondrostereum sp. Mar. Drugs 2012, 10, 627-638.
155. Yang, F.; Chen, W.D.; Deng, R.; Li, D.D.; Wu, K.W.; Feng, G.K.; Li, H.J.; Zhu, X.F. Hirsutanol A induces apoptosis and autophagy via reactive oxygen species accumulation in breast cancer MCF-7 cells. J. Pharmacol. Sci. 2012, 119, 214-220.
156. Yang, F.; Chen, W.D.; Deng, R.; Zhang, H.; Tang, J.; Wu, K.W.; Li, D.D.; Feng, G.K.; Lan, W.J.; Li, H.J.; et al. Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: Hirsutanol A inhibits tumor growth through ROS production. J. Trans. Med. 2013, 11, 32.
157. Fenical, W.; Jensen, P.R.; Cheng, X.C. Halimide, a cytotoxic marine natural product, derivatives thereof. PCT Int. Appl. WO 1999048889 A1, 30 September 1999.
158. Fenical, W.; Jensen, P.R.; Cheng, X.C. Halimide, a Cytotoxic Marine Natural Product, and Derivatives thereof. US. Patent US6069146. 30 May 2000.
159. Fukumoto, K.; Kohno, S.; Kanoh, K.; Asari, T.; Kawashima, H.; Sekiya, H.; Ohmizo, K.; Harada, T. Phenylahistin and the Phenylahistin Analogs, a New Class of Anti-Tumor Compounds. US. Patent US6358957B1. 19 March 2002.
160. Kanoh, K.; Kohno, S.; Asari, T.; Harada, T.; Katada, J.; Muramatsu, M.; Kawashima, H.; Sekiya, H.; Uno, I. (-)-Phenylahistin: A new mammalian cell cycle inhibitor produced by Aspergillus ustus. Bioorg. Med. Chem. Lett. 1997, 7, 2847-2852.
161. Kanoh, K.; Kohno, S.; Katada, J.; Takahashi, J.; Uno, I. (-)-Phenylahistin arrests cells in mitosis by inhibiting tubulin polymerization. J. Antibiot. 1999, 52, 134-141.
162. Kanoh, K.; Kohno, S.; Katada, J.; Hayashi, Y.; Muramatsu, M.; Uno, I. Antitumor activity of phenylahistin in vitro and in vivo. Biosci. Biotechnol. Biochem. 1999, 63, 1130-1133.
163. Kanoh, K.; Kohno, S.; Katada, J.; Takahashi, J.; Uno, I.; Hayashi, Y. Synthesis and biological activities of phenylahistin derivatives. Bioorg. Med. Chem. 1999, 7, 1451-1457.
164. Hayashi, Y.; Orikasa, S.; Tanaka, K.; Kanoh, K.; Kiso, Y. Total synthesis of anti-microtubule diketopiperazine derivatives: Phenylahistin and aurantiamine. J. Org. Chem. 2000, 65, 8402-8405.
165. Nicholson, B.; Lloyd, G.K.; Miller, B.R.; Palladino, M.A.; Kiso, Y.; Hayashi, Y.; Neuteboom, S.T. NPI-2358 is a tubulin-depolymerizing agent: In vitro evidence for activity as a tumor vascular-disrupting agent. Anticancer Drugs 2006, 17, 25-31.
166. Yamazaki, Y.; Sumikura, M.; Hidaka, K.; Yasui, H.; Kiso, Y.; Yakushiji, F.; Hayashi, Y. Anti-microtubule "plinabulin" chemical probe KPU-244-B3 labeled both α- and β-tubulin. Bioorg. Med. Chem. 2010, 18, 3169-3174.
167. Yamazaki, Y.; Tanaka, K.; Nicholson, B.; Deyanat-Yazdi, G.; Potts, B.; Yoshida, T.; Oda, A.; Kitagawa, T.; Orikasa, S.; Kiso, Y.; et al. Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure. J. Med. Chem. 2012, 55, 1056-1071.
168. Mita, M.M.; Spear, M.A.; Yee, L.K.; Mita, A.C.; Health, E.I.; Papadopoulos, K.P.; Federico, K.C.; Reich, S.D.; Romero, O.; Malburg, L.; et al. Phase 1 first-in-human trial of the vascular disrupting agent plinabulin (NPI-2358) in patients with solid tumors or lymphomas. Clin. Cancer Res. 2010, 16, 5892-5899.
169. Study of the Vascular Disrupting Agent NPI-2358 in Patients with Advanced Solid Tumors or Lymphoma. ClinicalTrials.gov. Available online: https://www.clinicaltrials.gov/ct2/show/NCT00322608?term=NPI-2358&rank=2 (accessed on 15 March 2015).
170. Heist, R.; Aren, O.; Millward, M.; Mainwaring, P.; Mita, A.; Mita, M.; Bazhenova, L.; Blum, R.; Polikoff, J.; Gadgeel, S.; et al. Phase 1/2 study of the vascular disrupting agent (VDA) plinabulin (NPI-2358) combined with docetaxel in patients with non-small cell lung cancer (NSCLC). Mol. Cancer Ther. 2009, 8, C30.
171. Millward, M.; Mainwaring, P.; Mita, A.; Federico, K.; Lloyd, G.K.; Reddinger, N.; Nawrocki, S.; Mita, M.; Spear, M.A. Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel. Invest. New Drugs 2012, 30, 1065-1073.
172. Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer. ClinicalTrials.gov. Available online: https://www.clinicaltrials.gov/ct2/show/NCT00630110?term=NPI-2358&rank=1 (accessed on 15 March 2015).
173. Kondo Y.; Shen, L.; Ahmed, S.; Boumber, Y.; Sekido, Y.; Haddad, B.R.; Issa, J.P.J. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS ONE 2008, 3, e2037.
174. Lee, S.H.; Kim, J.; Kim, W.H.; Lee, Y.M.; Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 2009, 28, 184-194.
175. Yuan, Y.; Tang, A.J.; Castoreno, A.B.; Kuo, S.Y.; Wang, S.Y.; Wang, Q.; Kuballa, P.; Xavier, R.; Shamji, A.F.; Schreiber, S.L.; Wagner, B.K. Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells. Cell Death Dis. 2013, 4, e690.
176. Adachi, Y.; Takeuchi, T.; Nagayama, T.; Furihata, M. T-cadherin modulates tumor-associated molecules in gallbladder cancer cells. Cancer Invest. 2010, 28, 120-126.
177. Mathieu, A.; Remmelink, M.; D'Haene, N.; Penant, S.; Gaussin, J.F.; van Ginckel, R.; Darro, F.; Kiss, R.; Salmon, I. Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: Analyses of tumor heterogeneity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-alpha (GST)-alpha-, GST-mu, and GST-pi. Cancer 2004, 101, 1908-1918.
178. Dumont, P.; Ingrassia, L.; Rouzeau, S.; Ribaucour, F.; Thomas, S.; Roland, I.; Darro, F.; Lefranc, F.; Kiss, R. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the Death Receptor and/or the mitochondrial pathways in cancer cells but not in normal fibroblasts. Neoplasia 2007, 9, 766-776.
179. Lefranc, F.; Brotchi, J.; Kiss, R. Possible future issues in the treatment of glioblastomas, with a special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol. 2005, 23, 2411-2422.
180. Bury, M.; Girault, A.; Megalizzi, V.; Spiegl-Kreinecker, S.; Mathieu, V.; Berger, W.; Evidente, A.; Kornienko, A.; Gailly, P.; Vandier, C.; et al. Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity. Cell Death Dis. 2013, 4, e561.
181. Chu, E. An update on the current and emerging targeted agents in metastatic colorectal cancer. Clin. Colorectal Cancer 2012, 11, 1-13.
182. Ravaud, A.; Gross-Goupil, M.; Bellmunt, J. Combination therapy in metastatic renal cell cancer. Semin. Oncol. 2013, 40, 472-481.
183. Saksena, R.; Wong, S.T. Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer. Breast Cancer (Dove Med. Press) 2013, 5, 27-35.
184. Beck, J.T.; Ismail, A.; Tolomeo, C. Targeting the phosphatidylinositol 3-kinase (PI3K)AKT/mammalian target of rapamycin (mTOR) pathway: An emerging treatment strategy for squamous cell lung carcinoma. Cancer Treat. Rev. 2014, 40, 980-989.
185. Soengas, M.S.; Lowe, S.W. Apoptosis and melanoma chemoresistance. Oncogene 2003, 22, 3138-3151.
186. Mathieu, V.; Mijatovic, T.; van Damme, M.; Kiss, R. Gastrin exerts pleitropic effects on human melanoma cell biology. Neoplasia 2005, 7, 930-943.
187. Chiarugi, P.; Giannoni, E. Anoikis: A necessary death program for anchorage-dependent cells. Biochem. Pharmacol. 2008, 76, 1352-1364.
188. Simpson, C.D.; Anyiwe, K.; Schimmer, A.D. Anoikis resistance and tumor metastasis. Cancer Lett. 2008, 272, 177-185.
189. Wong, H.H.; Lemoine, N.R. Pancreatic cancer: Molecular pathogenesis and new therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 2009, 6, 412-422.
190. Bussink, J.; van Herpen, C.; Kaanders, J.; Oyen, W. PET-CT for response assessment and treatment adaptation in head and neck cancer. Lancet Oncol. 2010, 11, 661-669.
191. Kennedy, B.; Gargoum, F.; Bystricky, B.R.; Curran, D.M.; O'Connor, T. Novel agents in the management of lung cancer. Curr. Med. Chem. 2010, 17, 4291-4325.